Sutro Biopharma, Inc.STRONASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-378.57%
↓ 397% below average
Average (34q)
-76.15%
Historical baseline
Range
High:219.05%
Low:-995.00%
Volatility
-1594.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -378.57% |
| Q2 2025 | 84.62% |
| Q1 2025 | -3.41% |
| Q4 2024 | -49.15% |
| Q3 2024 | 0.00% |
| Q2 2024 | 37.89% |
| Q1 2024 | -286.27% |
| Q4 2023 | 162.96% |
| Q3 2023 | -26.56% |
| Q2 2023 | 24.71% |
| Q1 2023 | -30.77% |
| Q4 2022 | -91.18% |
| Q3 2022 | 38.18% |
| Q2 2022 | 34.52% |
| Q1 2022 | -1.20% |
| Q4 2021 | -23.88% |
| Q3 2021 | -415.38% |
| Q2 2021 | 80.30% |
| Q1 2021 | 59.01% |
| Q4 2020 | -450.00% |
| Q3 2020 | -54.00% |
| Q2 2020 | 219.05% |
| Q1 2020 | -31.25% |
| Q4 2019 | -14.29% |
| Q3 2019 | 6.67% |
| Q2 2019 | 3.23% |
| Q1 2019 | -849.46% |
| Q4 2018 | 85.49% |
| Q3 2018 | 13.46% |
| Q2 2018 | 69.77% |
| Q1 2018 | 21.46% |
| Q4 2017 | -995.00% |
| Q3 2017 | 93.98% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |